What does its a hard cookie we have here mean? Just curious
I do agree with your comment about having the wrong kind of share structure with not enough institutional investors and to many flippers. But unless they can produce something and turn the corner and maintain a higher share price that will be tough to change
But, in my opinion it appears with all the volatility of the past two weeks that A) with the low float we have purged out many holders in the low 3s and B)now we may have a new range of between 3.80 and 4 ish as opposed to 3.25 to 3.50 where it seemed to be in the last 6 months previous. So if that holds true its a little bit better and hopefully in the very near future we will know with FDA approvals (fingers crossed) where the next stop will be.
We all know this companies financials are horrible and the only way we will see a significant change is FDA approval which will hopefully then lead to marketing of Zoptrex and Macrilen. Zoptrex seems to have a bigger immediate upside with the signed partners. I'm curious to hear if the conference call has any clues to time frames.
News 
Market Data 
Discover 
